Cell ImpactFRA:ICL 25 Pretax Margin % is -848.02% as of Mar. 2026. GuruFocus rates FRA:ICL with a GF Score™ of 25/100 and a GF Value™ of €0.01 (Fairly Valued). The stock has 7 warning signs investors should review. Among 3,031 Industrial Products companies, Cell Impact ranks worse than 99.27% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cell Impact's Pre-Tax Income for the
three
months ended in Mar. 2026 was €-1.71 Mil. Cell Impact's Revenue for the
three
months ended in Mar. 2026 was €0.20 Mil. Therefore, Cell Impact's pretax margin for the quarter that ended in Mar. 2026 was -848.02%.
The historical rank and industry rank for Cell Impact's Pretax Margin % or its related term are showing as below:
FRA:ICL'
s Pretax Margin % Range Over the Past 10 Years
Min: -2369.46 Med: -337.47 Max: -111.75
Current: -2219.11
FRA:ICL's Pretax Margin % is ranked worse than 99.27% of 3031
companies
in the Industrial Products industry
Industry Median: 5.85
vs FRA:ICL: -2219.11
Cell Impact (FRA:ICL) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Cell Impact Pretax Margin % Related Terms
Cell Impact Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Cell Impact's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ICL vs CRS, ATI, MLI: Pretax Margin % Comparison
For the Metal Fabrication subindustry, Cell Impact's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Impact Pretax Margin % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Cell Impact's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Cell Impact's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Impact (FRA:ICL) has a Pretax Margin % of -848.02% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #3009 out of 3031 companies in the Industrial Products industry, placing it in the top 99.3%.
Is Cell Impact's Pretax Margin % too high?
Cell Impact's current Pretax Margin % is -848.02%. Based on the distribution chart, Cell Impact ranks #3009 out of 3031 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Cell Impact has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cell Impact's Pretax Margin % compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #3009 out of 3031 companies for Pretax Margin %. This places Cell Impact in the lower half of its industry. The industry median Pretax Margin % is 5.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for an Industrial Products company?
The median Pretax Margin % among Industrial Products companies is 5.85, based on 3,031 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median Pretax Margin % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current Pretax Margin % is -848.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (FRA:ICL) is currently considered Fairly Valued. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading right at its estimated fair value. The current Pretax Margin % is -848.02%. Cell Impact's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Cell Impact (FRA:ICL), the current Pretax Margin % is -848.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cell Impact (FRA:ICL) Overvalued in 2026?
Based on GuruFocus' analysis, Cell Impact stock appears to be undervalued.
The current stock price of €0.01 is trading 0% below its estimated GF Value™ of €0.01.
GuruFocus considers Cell Impact to be Fairly Valued.
Key valuation signals for FRA:ICL:
Pretax Margin %: -848.02%
GF Value™: €0.01 vs. price of €0.01 (0% below fair value)
No single metric tells the full story. See the FRA:ICL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.
25GF Score
Get the complete analysis for FRA:ICL
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ICL has been successfully added to your 
